Results 61 to 70 of about 10,940 (177)

Urinary Fungal Microbiome and Associations With Overactive Bladder, Antibiotics and Therapy Response

Neurourology and Urodynamics, Volume 45, Issue 3, Page 435-445, March 2026.
ABSTRACT Objective To characterize and compare the fungal urinary microbiome (“mycobiome”) in healthy women and those with overactive bladder (OAB), and secondarily compare the mycobiome by comorbidities, recent antibiotic exposure, and response to OAB therapy. Material and Methods DNA was isolated from urine of those with and without OAB and underwent
Glenn T. Werneburg, Michael D. Gross, Daniel R. Hettel, Madison Lyon, Sean McSweeney, Stacy H. Jeong, Jacob M. Knorr, Ava Adler, Thien Dang, Peace Orji, Suruchi Ramanujan, Emily Slopnick, Howard B. Goldman, Sandip P. Vasavada, Aaron W. Miller   +14 more
wiley   +1 more source

The efficacy and Safety of Intravesical Bacillus-Calmette-Guerin in the Treatment of Female Patients with Interstitial Cystitis: A double-blinded Prospective Placebo Controlled Study

Urology Journal, 2004
Purpose: To evaluate the efficacy and safety of intravesical Bacillus Calmette-Gurein injection in the treatment of female patients with interstitial cystitis.
AA Khezri, M Heidari, Darioush Irani
doaj  

Pulsed Electromagnetic Field Therapy as a Complementary Alternative for Chronic Pelvic Pain Management in an Interstitial Cystitis/Bladder Pain Syndrome Patient

Case Reports in Urology, 2019
Interstitial cystitis/bladder pain syndrome is a chronic pelvic pain condition with no known etiology that affects millions of women and men in the United States.
Tyler L. Overholt, Christina Ross, Robert J. Evans, Stephen J. Walker   +3 more
doaj   +1 more source

Non‐Pulmonary Mechanisms of Action of Ambroxol in In Vivo Experimental Models: a Systematic Review

Fundamental &Clinical Pharmacology, Volume 40, Issue 2, March 2026.
ABSTRACT Background Repositioning offers a cost‐effective approach to discovering new therapeutic applications for existing medications. Ambroxol, primarily used as a mucolytic for respiratory diseases, has demonstrated anti‐inflammatory, analgesic, and antioxidant properties, suggesting potential benefits in non‐pulmonary conditions.
Michelline Joana Tenório Albuquerque Madruga Mesquita, Anne Caroline Silva Nogueira da Cruz, Rafael de Abreu Lima, Joana Tenório‐Meireles, Arney José Nogueira Farias, Isabela Nogueira Santos, Gustavo Frota, Taciana Gabrielle Pinheiro de Moura Carvalho, Rafael Antônio Freire Carvalho, Jorge Antônio Meireles‐Teixeira, Tereza Prazeres, Rafael Cardoso Carvalho, Maria do Socorro de Sousa Cartágenes, João Batista Santos Garcia   +13 more
wiley   +1 more source

Precision‐Cut Bladder Slices: A Novel Model for the Study of Bladder Fibrosis and Potential Anti‐Fibrotic Agents

International Journal of Urology, Volume 33, Issue 3, March 2026.
ABSTRACT Objectives Precision‐cut tissue slice culture is an innovative ex vivo approach for studying fibrosis pathogenesis. Here, we report for the first time the use of human precision‐cut bladder slices (PCBS) to investigate fibrotic changes and evaluate anti‐fibrotic compounds.
Yutao Lu, Natasja Patricia Simonsen, Jens Christian Djurhuus, Lars Henning Olsen, Henricus Antonius Maria Mutsaers, Rikke Nørregaard   +5 more
wiley   +1 more source

Long‐Term Safety of Desmopressin Orally Disintegrating Tablets in Men With Nocturia due to Nocturnal Polyuria: Final Results of a Specified Drug Use‐Results Survey in Japan

LUTS: Lower Urinary Tract Symptoms, Volume 18, Issue 2, March 2026.
ABSTRACT Objectives This report presents the final results of a post‐marketing surveillance evaluating the safety of desmopressin orally disintegrating tablets (ODT) in Japanese men with nocturia due to nocturnal polyuria (NP). Methods In total, 1113 Japanese men who received desmopressin ODT for the first time to treat nocturia due to NP were enrolled
Yoshimasa Ogawa, Kiyotoshi Kuramoto, Atsushi Nakano   +2 more
wiley   +1 more source

Interstitial Cystitis/Bladder Pain Syndrome in Persian Medicine view

Traditional and Integrative Medicine, 2018
Bladder pain syndrome or interstitial cystitis is a disagreeable feeling of pain, pressure and discomfort in the urinary bladder, along with lower urinary tract symptoms that may last more than six weeks with no infection or any other identifiable cause.
Zahra Niktabe, Nematollah Masoudi, Maryam Hajhashemy, Tahereh Foroughifar, Malihe Tabarrai   +4 more
doaj  

BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis

Journal of Neuroinflammation, 2020
Background Patients with interstitial cystitis/bladder pain syndrome (IC/BPS) often grieve over a low quality of life brought about by chronic pain.
Honglu Ding, Jialiang Chen, Minzhi Su, Zhijun Lin, Hailun Zhan, Fei Yang, Wenbiao Li, Juncong Xie, Yong Huang, Xianguo Liu, Bolong Liu, Xiangfu Zhou   +11 more
doaj   +1 more source

Gap of Research to Practice in IC/BPS: A Scientometric Study of Available Evidence

Urology Research and Practice
Our main objective is to first characterize the current status of the research field of interstitial cystitis and bladder pain syndrome (IC/BPS). This is achieved by mapping, analyzing, and sub-analyzing the field with a scientometric approach, which ...
Helia Mostafaei, Hamidreza Ashayeri, Sayeh Afshar, Hadi Mostafaei, Tannaz Aghaei Badr, Hanieh Salehi-pourmehr, Sakineh Hajebrahimi   +6 more
doaj   +1 more source

Avicenna`s Point about Bladder Gas as a Cause of Interstitial Cystitis

Iranian Journal of Public Health, 2018
Avicenna`s Point about Bladder Gas as a Cause of Interstitial ...
Malihe TABARRAI, Zahra NIKTABE, Nematollah MASOUDI, Tahereh EFTEKHAAR   +3 more
doaj